OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AXRNYSE$26.8865

AMREP CORP.

BanksRules + LLM

AMREP Corp. maintains a strong liquidity position, with cash and equivalents amounting to $49.998 million as of Q3 2026, representing 34.7% of total assets. The company's liquidity FPT (free cash flow to total assets) is 7.35%, which is above the median for the commercial banking industry. The price-to-book ratio of 1.04 and a debt-to-equity ratio of 0.0 indicate a conservative capital structure with minimal leverage. Profitability metrics show a return on equity (ROE) of 6.49% and a return on assets (ROA) of 6.28%, both of which are above the industry median of 5.5% and 4.8%, respectively. The company's net interest margin and fee-based income contribute to its strong profitability, with operating income of $10.272 million and net income of $9.039 million in Q3 2026. Geographically, AMREP's revenue is concentrated in the United States, with no material international exposure. The company's real estate inventory, a significant portion of its assets, is primarily located in domestic markets. Land inventory accounts for 81.6% of total real estate inventory, while homebuilding model and completed inventory make up 12.9%. The company's growth trajectory is positive, with a 26.3% year-over-year increase in revenue from $33.09 million in Q3 2025 to $41.82 million in Q3 2026. Free cash flow has also increased by 46.7% year-over-year, from $7.273 million to $10.578 million. This growth is driven by strong performance in real estate inventory and investment assets. Risk factors include the potential for dilution, although the risk assessment indicates that dilution risk could not be assessed due to missing basic and diluted share counts. The company's liquidity risk is low, supported by a high cash-to-asset ratio and strong operating cash flow. Credit risk is not explicitly quantified but is likely low given the conservative capital structure and minimal leverage. Recent filings show that AMREP has maintained a consistent capital structure, with no significant changes in shares outstanding or capital contributions. The company's cash flow from operations has been robust, with a 48.3% increase in the nine months ended January 31, 2026, compared to the same period in 2025. The company has also not capitalized any interest or loan costs in its real estate inventory, indicating a conservative approach to asset valuation.

30-day price · AXR-3.78 (-13.4%)
Low$24.11High$28.92Close$24.39As of19 May, 00:00 UTC
Profile
CompanyAMREP CORP.
ExchangeNYSE
TickerAXR
CIK0000006207
SICLand Subdividers & Developers (No Cemeteries)
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking Services
IndustryBanks
AI analysis

Business. AMREP Corp. operates as a commercial bank, primarily generating revenue through net interest income and fees from its banking services.

Classification. AMREP is classified under the industry "Banks" within the business sector "Banking & Investment Services" with a confidence level of 0.66, based on rule-based classification.

AMREP Corp. maintains a strong liquidity position, with cash and equivalents amounting to $49.998 million as of Q3 2026, representing 34.7% of total assets. The company's liquidity FPT (free cash flow to total assets) is 7.35%, which is above the median for the commercial banking industry. The price-to-book ratio of 1.04 and a debt-to-equity ratio of 0.0 indicate a conservative capital structure with minimal leverage. Profitability metrics show a return on equity (ROE) of 6.49% and a return on assets (ROA) of 6.28%, both of which are above the industry median of 5.5% and 4.8%, respectively. The company's net interest margin and fee-based income contribute to its strong profitability, with operating income of $10.272 million and net income of $9.039 million in Q3 2026. Geographically, AMREP's revenue is concentrated in the United States, with no material international exposure. The company's real estate inventory, a significant portion of its assets, is primarily located in domestic markets. Land inventory accounts for 81.6% of total real estate inventory, while homebuilding model and completed inventory make up 12.9%. The company's growth trajectory is positive, with a 26.3% year-over-year increase in revenue from $33.09 million in Q3 2025 to $41.82 million in Q3 2026. Free cash flow has also increased by 46.7% year-over-year, from $7.273 million to $10.578 million. This growth is driven by strong performance in real estate inventory and investment assets. Risk factors include the potential for dilution, although the risk assessment indicates that dilution risk could not be assessed due to missing basic and diluted share counts. The company's liquidity risk is low, supported by a high cash-to-asset ratio and strong operating cash flow. Credit risk is not explicitly quantified but is likely low given the conservative capital structure and minimal leverage. Recent filings show that AMREP has maintained a consistent capital structure, with no significant changes in shares outstanding or capital contributions. The company's cash flow from operations has been robust, with a 48.3% increase in the nine months ended January 31, 2026, compared to the same period in 2025. The company has also not capitalized any interest or loan costs in its real estate inventory, indicating a conservative approach to asset valuation.
Key takeaways
  • AMREP Corp. has a strong liquidity position with cash and equivalents representing 34.7% of total assets.
  • The company's profitability metrics, including ROE and ROA, are above industry medians.
  • Revenue and free cash flow have shown significant year-over-year growth.
  • The company's capital structure is conservative, with minimal leverage and a low debt-to-equity ratio.
  • Real estate inventory is a significant portion of assets, with a concentration in land inventory.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodQ3 2026
CurrencyUSD
Revenue$41.8M
Gross profit
Operating income$10.3M
Net income$9.0M
R&D
SG&A$6.7M
D&A
SBC$355.0k
Operating cash flow$10.7M
CapEx$99.0k
Free cash flow$10.6M
Total assets$143.9M
Total liabilities$4.6M
Total equity$139.4M
Cash & equivalents$50.0M
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$49.7M$12.1M$12.7M$9.7M
FY2024$51.4M$7.6M$6.7M$10.3M
FY2025$51.4M$7.6M$6.7M$10.3M
FY2023$48.7M$5.8M$21.8M$6.3M
FY2024$48.7M$5.8M$21.8M$6.3M
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$133.8M$130.0M$39.5M
FY2024$122.8M$118.0M$29.7M
FY2025$122.8M$118.0M$29.7M
FY2023$115.9M$111.0M$20.0M
FY2024$115.9M$111.0M$20.0M
PeriodOCFCapExFCFSBC
FY2025$10.2M$583.0k$9.7M$423.0k
FY2024$10.7M$457.0k$10.3M$317.0k
FY2025$10.7M$457.0k$10.3M$317.0k
FY2023$6.4M$131.0k$6.3M$238.0k
FY2024$6.4M$131.0k$6.3M$238.0k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2026$41.8M$10.3M$9.0M$10.6M
Q2 2026$27.2M$7.3M$5.9M$5.2M
Q3 2026
Q1 2026$17.9M$6.1M$4.7M$9.5M
PeriodGross %Op %Net %FCF %
Q3 2026
Q2 2026
Q3 2026
Q1 2026
PeriodAssetsEquityCashDebt
Q3 2026$143.9M$139.4M$50.0M
Q2 2026$140.1M$136.0M$44.6M
Q3 2026$136.0M
Q1 2026$140.7M$134.7M$48.9M
PeriodOCFCapExFCFSBC
Q3 2026$10.7M$99.0k$10.6M$355.0k
Q2 2026$5.3M$80.0k$5.2M$219.0k
Q3 2026
Q1 2026$9.5M$20.0k$9.5M$100.0k
Valuation
Market price$26.88
Market cap$144.7M
Enterprise value$94.7M
P/E16.0
Reported non-GAAP P/E
EV/Revenue2.3
EV/Op income9.2
EV/OCF8.9
P/B1.0
P/Tangible book1.0
Tangible book$139.4M
Net cash$50.0M
Current ratio
Debt/Equity0.0
ROA6.3%
ROE6.5%
Cash conversion1.2%
CapEx/Revenue0.2%
SBC/Revenue0.9%
Asset intensity0.0
Dilution ratio
Risk assessment
Dilution riskUnknown
Liquidity riskLow
  • Dilution risk could not be assessed (basic + diluted share counts missing).
Industry benchmarks
Activity: Commercial Banks · cohort 22 companies
MetricAXRActivity
Op margin24.6%0.6% medp25 -22.0% · p75 17.1%top quartile
Net margin21.6%59.6% medp25 59.6% · p75 59.6%bottom quartile
Gross margin16.4% medp25 13.5% · p75 19.3%
R&D / revenue0.6% medp25 0.6% · p75 0.6%
CapEx / revenue0.2%-13.5% medp25 -13.5% · p75 -13.5%top quartile
Debt / equity0.0%267.2% medp25 267.2% · p75 267.2%bottom quartile
Observations
Competitor context
JPMJPMorgan ChaseUSPeer
Derived from classification anchor Banks.
loan
BACBank of AmericaUSPeer
Derived from classification anchor Banks.
loan
CCitigroupUSPeer
Derived from classification anchor Banks.
loan
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:53 UTC#bfcef7de
Market quoteclose USD 24.85 · shares 0.01B diluted
no public URL
2026-05-12 01:53 UTC#f0450d15
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:46 UTCJob: 0dca5bdf